BIOCRYST Trademark

Trademark Overview


On Friday, August 10, 2018, a trademark application was filed for BIOCRYST with the United States Patent and Trademark Office. The USPTO has given the BIOCRYST trademark a serial number of 88073891. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, August 5, 2025. This trademark is owned by BioCryst Pharmaceuticals, Inc.. The BIOCRYST trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for the treatment of infectious, viral, inflammatory, immunological, autoimmune and cardiovascular diseases and disorders; pharmaceuticals for the treatment of hereditary angioedema, inflammatory bowel diseases, inflammatory connective tissue diseases and inflammatory skin diseases; pharmaceuticals for the treatment of influenza, AIDS, SARS, Ebola, Zika, and West Nile virus; pharmaceuticals for the treatment of transplant rejection; anti-infective pharmaceuticals; pharmaceuticals for the treatment of cancer, namely, cancers of the immune system such as T-cell and B-cell leukemias and lymphomas
biocryst

General Information


Serial Number88073891
Word MarkBIOCRYST
Filing DateFriday, August 10, 2018
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, August 5, 2025
Registration Number5713814
Registration DateTuesday, April 2, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 15, 2019

Trademark Statements


Goods and ServicesPharmaceuticals for the treatment of infectious, viral, inflammatory, immunological, autoimmune and cardiovascular diseases and disorders; pharmaceuticals for the treatment of hereditary angioedema, inflammatory bowel diseases, inflammatory connective tissue diseases and inflammatory skin diseases; pharmaceuticals for the treatment of influenza, AIDS, SARS, Ebola, Zika, and West Nile virus; pharmaceuticals for the treatment of transplant rejection; anti-infective pharmaceuticals; pharmaceuticals for the treatment of cancer, namely, cancers of the immune system such as T-cell and B-cell leukemias and lymphomas

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, August 18, 2018
Primary Code005
First Use Anywhere DateTuesday, August 14, 2007
First Use In Commerce DateTuesday, August 14, 2007

Trademark Owner History


Party NameBIOCRYST PHARMACEUTICALS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressDURHAM, NC 27703

Party NameBioCryst Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDurham, NC 27703

Party NameBioCryst Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDurham, NC 27703

Party NameBioCryst Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDurham, NC 27703

Trademark Events


Event DateEvent Description
Tuesday, August 14, 2018NEW APPLICATION ENTERED
Saturday, August 18, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, November 28, 2018ASSIGNED TO EXAMINER
Monday, December 3, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 26, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 15, 2019PUBLISHED FOR OPPOSITION
Tuesday, January 15, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 2, 2019REGISTERED-PRINCIPAL REGISTER
Friday, April 16, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, April 16, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 16, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 16, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 16, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, May 6, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 6, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 6, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 21, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 21, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 21, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 3, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, April 2, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, April 1, 2025TEAS SECTION 8 & 15 RECEIVED
Tuesday, August 5, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, August 5, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, August 5, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, December 2, 2025ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, December 3, 2025ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, December 3, 2025AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP